mitiglinide and Insulinoma
mitiglinide has been researched along with Insulinoma in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Ichikawa, K; Kojima, M; Kusama, H; Ojima, K; Tsuji, A; Yamato, T | 1 |
Kojima, I; Miyazaki, J; Mogami, H; Nobusawa, R; Ohnota, H; Satou, F; Shibata, H | 1 |
Other Studies
2 other study(ies) available for mitiglinide and Insulinoma
Article | Year |
---|---|
Study of the insulinotropic effect of the novel antihyperglycemic agent KAD-1229 using HIT T15 cells, a hamster's insulinoma cell line.
Topics: Animals; Calcium Channel Blockers; Cell Line; Cell Membrane; Cricetinae; Glucose; Glyburide; Hypoglycemic Agents; Indoles; Insulin; Insulinoma; Islets of Langerhans; Isoindoles; Pancreatic Neoplasms; Potassium Channels; Rubidium Radioisotopes | 2002 |
Inhibition of ATP-sensitive K+ channel by a non-sulfonylurea compound KAD-1229 in a pancreatic beta-cell line, MIN 6 cell.
Topics: Action Potentials; Adenosine Triphosphate; Binding, Competitive; Calcium; Cell Membrane; Cobalt; Dose-Response Relationship, Drug; Drug Synergism; Fura-2; Glucose; Glyburide; Humans; Hypoglycemic Agents; Indoles; Insulin; Insulin Secretion; Insulinoma; Islets of Langerhans; Isoindoles; Membrane Potentials; Nifedipine; Pancreatic Neoplasms; Patch-Clamp Techniques; Potassium Channel Blockers; Tumor Cells, Cultured | 1994 |